Pfizer : PFE

All Pfizer Articles

1518 Articles

Lee Jackson | Feb 5, 2019 at 7:20 AM EST

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

These four solid companies have released good earnings and pay consistent and healthy dividends. All make more sense going forward…

Jon C. Ogg | Jan 31, 2019 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell,…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 29, 2019 at 9:25 AM EST

Why Pfizer Fell Short in Q4

Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.

Chris Lange | Jan 28, 2019 at 10:15 AM EST

What to Expect When Pfizer Reports Tuesday

Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest…

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 27, 2019 at 10:20 AM EST

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this…

Chris Lange | Jan 24, 2019 at 9:50 AM EST

How the 30 Dow Stocks Are Doing in 2019

24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price.…

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 2, 2019 at 7:55 AM EST

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average…

Jon C. Ogg | Dec 31, 2018 at 2:20 PM EST

Meet the 2019 Dogs of the Dow

Investors love their dividends. So 24/7 Wall St. has tracked the Dogs of the Dow strategy for years now.

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Dec 26, 2018 at 10:10 AM EST

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

These six safer stocks all carry Merrill Lynch’s best volatility risk rating and pay dependable dividends. They offer reasonable entry…

Chris Lange | Dec 19, 2018 at 11:40 AM EST

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will…

1 … 32 33 34 35 36 … 102

Pfizer : PFE

All Pfizer Articles

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Why Pfizer Fell Short in Q4

What to Expect When Pfizer Reports Tuesday

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

T-Bill Returns Without the Annual Tax Bill: The $12 Billion Fund Using an Options Trick

Like It or Not, Apple Built a Perfect Mousetrap, So I Keep on Buying

The Most Basic Economics Lesson Is Why I Won’t Stop Buying Nvidia This Earnings Season

You Can Go Decades on Original Medicare and Never Get a Covered Pair of Glasses. Here's the One Loophole.

She Chose Retirement Over the Next Tech Overhaul. It Unlocked a Hidden Social Security Window.

T-Bill Returns Without the Annual Tax Bill: The $12 Billion Fund Using an Options Trick

Like It or Not, Apple Built a Perfect Mousetrap, So I Keep on Buying

Pfizer : PFE

All Pfizer Articles

Why It Is Time to Sell the Rally and Buy Safe Dividend Stocks

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Why Pfizer Fell Short in Q4

What to Expect When Pfizer Reports Tuesday

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

T-Bill Returns Without the Annual Tax Bill: The $12 Billion Fund Using an Options Trick

Like It or Not, Apple Built a Perfect Mousetrap, So I Keep on Buying

The Most Basic Economics Lesson Is Why I Won’t Stop Buying Nvidia This Earnings Season

Featured Reads

You Can Go Decades on Original Medicare and Never Get a Covered Pair of Glasses. Here's the One Loophole.

She Chose Retirement Over the Next Tech Overhaul. It Unlocked a Hidden Social Security Window.